NLRP3 and Insulin resistance: Measures taken against the assembly and activity of the NLRP3 (nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3) inflammasome may be a potential and novel therapy for cerebrovascular ischemic disease concomitant with insulin resistance (63).